Cite
APA Citation
Huang, W., Chen, H., Yeh, C., Lu, Y., Hwang, W., Huang, J., Chen, C., Lin, P., Uen, W., Lee, Y., Wang, H., Wu, H., Chen, J., Kao, R., Huang, C., Jeng, H., Lin, C., & Hsieh, R. (2013). a Postmarketing Surveillance Study on Erbitux (Cetuximab) in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-Containing Treatment. Journal of investigative medicine, 61, 1108–1114. http://access.bl.uk/ark:/81055/vdc_100135165463.0x00001a